A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in DMD mouse models have struggled to conclusively detect anxiety-like behaviour in mdx/bl10 mice (Vaillend et al., 1995; Sekiguchi et al., 2009; Comim et al., 2019) and to produce consistent results, detecting anxiety-like behaviour in the open field test, but not in the dark–light box or the elevated plus maze (Manning et al., 2014; Remmelink et al., 2016; Vaillend and Chaussenot, 2017;”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Sekiguchi et al., 2009
In the citing paper
“This altered freezing response can be exhibited as early as 36 days after birth (Sekiguchi et al., 2009).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Sekiguchi et al., 2009
In the citing paper
“The most prominent phenotype of the mdx/bl10 mouse is the severe fear response, in which a short stressor (i.e. manual restraint) instantly causes freezing behaviour that lasts for at least 1 h”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Sekiguchi et al., 2009
In the citing paper
“As a result, mdx/bl10 mice present with altered neuronal firing patterns, impaired synaptic plasticity and behavioural abnormalities (Knuesel et al., 1999; Vaillend and Billard, 2002; Sekiguchi et al., 2009; Anderson et al., 2010; Dallérac et al., 2011; Vaillend and Chaussenot, 2017; Zarrouki et al., 2022a).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Sekiguchi et al., 2009
In the citing paper
“Exon 23 skipping led to restoration of 25% of dystrophin over a time frame similar to that reported for ICV injections with tc-DNA AONs, with optimal restoration seen between 5 and 7 weeks after treatment initiation, and a significant drop in restoration 11 weeks after treatment.”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Sekiguchi et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765 · cited 15×
“The verbal intelligence quotient (IQ) of DMD patients is significantly lower than that of normal controls, but their performance IQ is normal (Billard et al., 1992).”
BackgroundMethodInfluentialThe Amygdaloid Complex: Anatomy and Physiology
SAH, P., FABER, E. S. L., LOPEZ DE ARMENTIA, M., & POWER, J. (2003) · Physiological Reviews · doi:10.1152/physrev.00002.2003 · Cited by 1,745 · cited 4×
“…activity in the amygdala, the alteration of fear-motivated unconditioned and conditioned defensive responses in mdx mice is consistent with these previous findings, because local GABAergic inhibition is one of the crucial factors regulating amygdala neuronal circuit activity (Sah et al., 2003).”
BackgroundMethodResultInfluentialLeDoux, J., Iwata, J., Cicchetti, P., & Reis, D. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-07-02517.1988 · Cited by 1,580
The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point Mutation
Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., & Barnard, P. J. (1989) · Science · doi:10.1126/science.2662404 · Cited by 1,276
Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550 · cited 2×
“Because psychiatric symptoms are reported in DMD patients, as mentioned above, and because decreased GABAA receptor clustering results in enhanced anxiety and a bias for threat cues (Crestani et al., 1999), information on the emotional aspects of mdx mice is likely to be significant.”
BackgroundThe Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01276-7 · Cited by 295
Neurochemical mechanisms of the defensive behavior in the dorsal midbrain
Brandão, M. L., Anseloni, V. Z., Pandóssio, J. E., De Araújo, J. E., & Castilho, V. M. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00038-x · Cited by 280 · cited 2×
“Downloaded from https://academic.oup.com/brain/article-abstract/132/1/124/286929 by guest on 29 July 2018 system composed of the medial hypothalamus, the dorsal periaqueductal grey (dPAG) and superior and inferior colliculi (Brandao et al., 1999).”
BackgroundMethodNoradrenergic Excitation and Inhibition of GABAergic Cell Types in Rat Frontal Cortex
Kawaguchi, Y., & Shindou, T. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-17-06963.1998 · Cited by 230 · cited 4×
“In the rat BLA, somatostatin-containing nonpyramidal neurons, which respond to NE with action potential firing in rat frontal cortex (Kawaguchi and Shindou, 1998), make synaptic contacts with the distal dendrites of pyramidal cells (Muller et al., 2007).”
BackgroundMethodResultInfluentialVaillend, C., Billard, J.-M., & Laroche, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.05.004 · Cited by 169
Research works printed but not linked: 51
- Alter, 2006, Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology, Nat Med, 12, 175, 10.1038/nm1345 · DOI · Paper page
- Amalfitano, 1996, The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele, Muscle Nerve, 19, 1549, 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A · DOI · Paper page
- Amano, 2008, Heightened amygdala long-term potentiation in neurotensin receptor type-1 knockout mice, 10.1038/npp.2008.38 · DOI
- Anderson, 2003, Altered inhibitory input to Purkinje cells of dystrophin-deficient mice, Brain Res, 982, 280, 10.1016/S0006-8993(03)03018-X · DOI
- Anderson, 2003, Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice, Brain Res, 1019, 289, 10.1016/j.brainres.2004.06.011 · DOI
- Billard, 1992, Cognitive functions in Duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy, Neuromuscul Disord, 2, 371, 10.1016/S0960-8966(06)80008-8 · DOI · Paper page
- Blanchard, 1972, Innate and conditioned reactions to threat in rats with amygdaloid lesions, J Comp Physiol Psychol, 81, 281, 10.1037/h0033521 · DOI · Paper page
- Braga, 2004, Stress impairs α1A adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala, Neuropsychopharmacol, 29, 45, 10.1038/sj.npp.1300297 · DOI
- Bresolin, 1994, Cognitive impairment in Duchenne muscular dystrophy, Neuromuscul Disord, 4, 359, 10.1016/0960-8966(94)90072-8 · DOI · Paper page
- Brunig, 2002, GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABAA receptors and gephyrin, J Neurosci, 22, 4805, 10.1523/JNEUROSCI.22-12-04805.2002 · DOI · Paper page
- Chelly, 1988, Transcription of the dystrophin gene in human muscle and non-muscle tissues, Nature, 333, 858, 10.1038/333858a0 · DOI · Paper page
- Dubowitz, 1969, The central nervous system in Duchenne muscular dystrophy, Brain, 92, 805, 10.1093/brain/92.4.805 · DOI · Paper page
- Emery, 1987, Central nervous system, 99
- Ervasti, 1991, Membrane organization of the dystrophin-glycoprotein complex, Cell, 66, 1121, 10.1016/0092-8674(91)90035-W · DOI · Paper page
- Fitzpatrick, 1986, Psychiatric disorder among boys with Duchenne muscular dystrophy, Dev Med Child Neurol, 28, 589, 10.1111/j.1469-8749.1986.tb03900.x · doi:10.1111/j.1469-8749.1986.tb03900.x
- Fritschy, 1998, Synapse-specific localization of NMDA and GABAA receptor subunits revealed by antigen-retrieval immunohistochemistry, J Comp Neurol, 399, 194, 10.1002/(SICI)1096-9861(19980112)390:2<194::AID-CNE3>3.0.CO;2-X · DOI · Paper page
- Galvez, 1996, Norepinephrine release in the amygdala in response to footshock stimulation, Neurobiol Learn Mem, 66, 253, 10.1006/nlme.1996.0067 · DOI · Paper page
- Graciotti, 2008, GABAergic miniature spontaneous activity is increased in the CA1 hippocampal region of dystrophic mdx mice, Neuromuscul Disord, 18, 220, 10.1016/j.nmd.2007.11.009 · DOI
- Graf, 2004, Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins, Cell, 119, 1013, 10.1016/j.cell.2004.11.035 · DOI · Paper page
- Im, 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Human Molec Genet, 5, 1149, 10.1093/hmg/5.8.1149 · DOI · Paper page
- Kang, 2006, Composition and assembly of GABAergic postsynaptic specializations, 277, 10.1007/978-0-387-32562-0_20 · DOI
- Kim, 1992, Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy, Proc Natl Acad Sci USA, 89, 11642, 10.1073/pnas.89.23.11642 · DOI · Paper page
- Kins, 2000, Collybistin, a newly identified brain-specific GEF, induces submembrane clustering of gephyrin, Nat Neurosci, 3, 22, 10.1038/71096 · DOI · Paper page
- Knuesel, 1999, Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice), Eur J Neurosci, 11, 4457, 10.1046/j.1460-9568.1999.00887.x · DOI · Paper page
- Komoto, 1984, Infantile autism and Duchenne muscular dystrophy, J Autism Dev Disord, 14, 191, 10.1007/BF02409661 · DOI
- LeDoux, 2000, Emotion circuits in the brain, Annu Rev Neurosci, 23, 155, 10.1146/annurev.neuro.23.1.155 · DOI · Paper page
- Levi, 2002, Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation, J Neurosci, 22, 4274, 10.1523/JNEUROSCI.22-11-04274.2002 · DOI · Paper page
- Lidov, 1993, The distribution of dystrophin in the murine central nervous system: an immunocytochemical study, Neuroscience, 54, 167, 10.1016/0306-4522(93)90392-S · DOI · Paper page
- Lidov, 1990, Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons, Nature, 348, 725, 10.1038/348725a0 · DOI · Paper page
- Maren, 1995, Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo, J Neurosci, 15, 7548, 10.1523/JNEUROSCI.15-11-07548.1995 · DOI · Paper page
- McDonald, 2004, Parvalbumin-containing interneurons in the basolateral amygdala express high levels of the alpha1 subunit of the GABAA receptors, J Comp Neurol, 473, 137, 10.1002/cne.20101 · DOI · Paper page
- Muller, 2007, Postsynaptic targets of somatostatin-containing interneurons in the rat basolateral amygdala, J Comp Neurol, 500, 513, 10.1002/cne.21185 · DOI · Paper page
- Muntoni, 1991, Passive avoidance behavior deficit in the mdx mouse, Neuromuscul Disord, 1, 121, 10.1016/0960-8966(91)90059-2 · DOI · Paper page
- Nakao, 2004, Amygdala stimulation modulates hippocampal synaptic plasticity, Proc Natl Acad Sci USA, 101, 14270, 10.1073/pnas.0405709101 · DOI · Paper page
- Neri, 2007, Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human, Neuromuscul Disord, 17, 913, 10.1016/j.nmd.2007.07.005 · DOI · Paper page
- Papadopoulos, 2007, Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice, EMBO J, 26, 3888, 10.1038/sj.emboj.7601819 · DOI · Paper page
- Pastoret, 1995, mdx mice show progressive weakness and muscle degeneration with age, J Neurol Sci, 129, 97, 10.1016/0022-510X(94)00276-T · DOI · Paper page
- Pentkowski, 2006, Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats, Eur J Neurosci, 23, 2185, 10.1111/j.1460-9568.2006.04754.x · DOI · Paper page
- Persohn, 1992, Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS, J Comp Neurol, 326, 193, 10.1002/cne.903260204 · DOI · Paper page
- Rainnie, 2006, Physiological and morphological characterization of parvalbumin-containing interneurons of the rat basolateral amygdala, J Comp Neurol, 498, 142, 10.1002/cne.21049 · DOI · Paper page
- Roccella, 2003, Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy, Minerva Pediatr, 55, 267
- Rodriguez Manzanares, 2005, Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala, J Neurosci, 25, 8725, 10.1523/JNEUROSCI.2260-05.2005 · DOI · Paper page
- Ruiz Martinez, 2006, Conditioned and unconditioned fear organized in the periaqueductal gray are differentially sensitive to injections of muscimol into amygdaloid nuclei, Neurobiol Learn Mem, 85, 58, 10.1016/j.nlm.2005.08.007 · DOI
- Sesay, 1996, Spatial learning and hippocampal long-term potentiation are not impaired in mdx mice, Neurosci Lett, 211, 207, 10.1016/0304-3940(96)12747-6 · DOI · Paper page
- Sugita, 2001, A stoichiometric complex of neurexins and dystroglycan in brain, J Cell Biol, 154, 435, 10.1083/jcb.200105003 · DOI · Paper page
- Suzuki, 1992, Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain, FEBS Lett, 308, 154, 10.1016/0014-5793(92)81265-N · DOI · Paper page
- Tanabe, 1986, Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse, Acta Neuropathol (Berl), 68, 91, 10.1007/BF00687043 · DOI · Paper page
- Tanaka, 1983, Regional characteristics of stress-induced increase in brain noradrenaline release in rats, Pharmacol Biochem Behav, 19, 543, 10.1016/0091-3057(83)90132-6 · DOI
- Wicksell, 2004, Specific cognitive deficits are common in children with Duchenne muscular dystrophy, Dev Med Child Neurol, 46, 154, 10.1111/j.1469-8749.2004.tb00466.x · DOI
- Yamada, 2002, Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice, Mol Psychiatry, 7, 113, 10.1038/sj.mp.4000974 · DOI
- Zushida, 2007, Facilitation of extinction learning for contextual fear memory by PEPA – a potentiator of AMPA receptors, J Neurosci, 27, 158, 10.1523/JNEUROSCI.3842-06.2007 · DOI · Paper page
Cited by
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018424 · Cited by 512
Ricotti, V., Mandy, W. P. L., Scoto, M., Pane, M., Deconinck, N., Messina, S., Mercuri, E., Skuse, D. H., & Muntoni, F. (2016) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12922 · Cited by 332
Goyenvalle, A., Griffith, G., Babbs, A., Andaloussi, S. E., Ezzat, K., Avril, A., Dugovic, B., Chaussenot, R., Ferry, A., Voit, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3765 · Cited by 327
Inhibition in the amygdala anxiety circuitry
Babaev, O., Piletti Chatain, C., & Krueger-Burg, D. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0063-8 · Cited by 308
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Sekiguchi, M., Zushida, K., Yoshida, M., Maekawa, M., Kamichi, S., Yoshida, M., Sahara, Y., Yuasa, S., Takeda, S., & Wada, K.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01
- Volume
- 132
- Issue
- 1
- Pages
- 124-135
- ISSN
- 1460-2156
- 0006-8950
- Cited by
- 147
- References
- 13
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.